Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Signaling Pathways

Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.


APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.


Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.

Items 11001-11010 of 11031

Page
per page
  1. Acetylsalicylic acid lithium
    C8731 Acetylsalicylic acid lithium
    Summary: An orally active, irreversible cyclooxygenase (COX-1 and COX-2) inhibitor, also commonly used to induce gastric ulcer models.
  2. N-Ethyl-N-nitrosourea
    C8733 N-Ethyl-N-nitrosourea
    Summary: A potent DNA alkylating agent commonly used to induce and establish animal tumor models
      ≥18.4 mg/mL
  3. Kainic acid monohydrate
    N2886 Kainic acid monohydrate
    Summary: Commonly used to establish neurodegenerative disease models
  4. Okadaic acid sodium
    N2887 Okadaic acid sodium
    Summary: A serine/threonine protein phosphatase (PP) inhibitor, commonly used to induce cell cycle arrest and apoptosis.
  5. (+)-Ofloxacin
    C8735 (+)-Ofloxacin
    Summary: The R-enantiomer of the fluoroquinolone antibacterial drug ofloxacin; forms a complex by binding bacterial DNA and DNA topoisomerase II (DNA gyrase), inhibiting DNA strand annealing and bacterial replication
      insoluble in DMSO; insoluble in EtOH; ≥25.35 mg/mL
  6. N-(6-Maleimidocaproyloxy)succinimide
    C8736 N-(6-Maleimidocaproyloxy)succinimide
    Summary: A heterobifunctional crosslinker commonly used in biomedical research
      ≥7.06 mg/mL
  7. Amiodarone
    C8737 Amiodarone
    Summary: Antiarrhythmic drug
  8. N-Butyl-N-(4-hydroxybutyl)nitrosamine
    C8738 N-Butyl-N-(4-hydroxybutyl)nitrosamine
    Summary: Commonly used to induce bladder cancer in animal models
      ≥31 mg/mL
  9. AAF
    C8739 AAF
    Summary: Mainly used to induce animal models for hepatocellular carcinoma (HCC) and multiple primary tumors
      ≥8.63 mg/mL
  10. 8-Epidiosbulbin E acetate
    N2890 8-Epidiosbulbin E acetate
    Summary: A furan compound with broad-spectrum plasmid-curing activity against multiple multidrug-resistant bacteria, including vancomycin-resistant enterococci
      ≥50.5 mg/mL

Items 11001-11010 of 11031

Page
per page